Growth Metrics

Pfizer (PFE) Change in Acquisitions & Divestments (2016 - 2025)

Pfizer (PFE) has disclosed Change in Acquisitions & Divestments for 16 consecutive years, with $4.7 billion as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments changed N/A to $4.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.0 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $18.0 billion for FY2025, 335.05% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $4.7 billion at Pfizer, up from $2.7 billion in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $35.1 billion in Q4 2022, with the low at $658.0 million in Q1 2024.
  • Average Change in Acquisitions & Divestments over 5 years is $8.2 billion, with a median of $5.5 billion recorded in 2021.
  • The sharpest move saw Change in Acquisitions & Divestments tumbled 89.72% in 2024, then surged 520.97% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at $15.9 billion in 2021, then skyrocketed by 121.34% to $35.1 billion in 2022, then plummeted by 39.45% to $21.2 billion in 2023, then plummeted by 87.62% to $2.6 billion in 2024, then soared by 79.58% to $4.7 billion in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $4.7 billion, $2.7 billion, and $6.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.